|
Import
Export > DEA Form 236 - Controlled Substances
Import/Export Declaration
DEA FORM 236
The application or declaration listed below
is available in PDF format in two ways – 1. As an interactive form
which can be completed on-line and printed on your printer, or 2. As
a blank form to be printed on your printer. This second version is not
recommended; fewer errors occur if the form is entered on-line and then
printed.
INSTRUCTIONS FOR COMPLETING FORM DEA-236
This form is to be used in notifying DEA of all Imports or
Exports as required by Title III, PL91-513, Sections 1002 and 1003, as
amended, (Controlled
Substances Import and Export Act, 21
U.S.C. 952 and 953).
This form may be prepared and signed by the actual Importer or Exporter or
by the Broker or
Forwarding Agent used. The following instructions
supplement the parts of the DEA-236 which are not completely
self-explanatory.
| Part 1.
|
"IMPORTER" means the authorized DEA
registrant who receives the controlled substance; "EXPORTER"
means the authorized DEA registrant
who ships the controlled substance.
|
| Part 2.
|
Typical entries might read |
Strength: |
10 mg tablets |
| |
Size or |
1,000 tablets/bottle
|
|
Weight (Bulk):
|
100 kilo/drum
|
|
Quantity:
|
100 bottles, 2 drums
|
If needed, use additional forms and distribute in the
prescribed manner after the required documents are attached to each copy.
|
| Part 3.
|
Self-explanatory.
|
| Part 4.
|
Insert name of vessel or airline and flight number,
together with all intermediate carriers. Furnish all information
concerning the transportation of the goods known at the time of preparing form DEA-236.
|
| Part 5.
|
Enter DEA registration number, if known, for "Import
Declaration", or foreign registration number, if applicable, for
"Export Declaration".
|
If this form is prepared as a Controlled Substance
Import Declaration, distribute as follows:
Copies 1, 2, and 3 must be forwarded to the foreign
shipper. These copies will accompany the shipment to certain points.
Upon receipt of Copies 1, 2, and 3, the foreign
shipper will present Copy 1 to the proper foreign government agency
or authority, if required, as a prerequisite to export authorization. Copy 1 shall
then accompany the shipment to its final destination and shall be retained
in the files of the importer for a period of at least two years.
Copy 2 shall be detached by the customs official at
the foreign port.
Copy 3 shall be removed by an official of the United
States Customs
and Border Protection at the port of entry, certified and signed by the
customs official
(after noting any discrepancies), and forwarded to the
Drug Enforcement Administration, Office of Diversion Control, Import
/ Export (ODGI)
8701 Morrissette Drive, Springfield, VA 22152.
Copy 4 must be forwarded at least 15 days prior to
importation to the Drug Enforcement Administration, Office of Diversion
Control,
Import / Export Unit.
Copy 5 must be retained by the importer until receipt
of Copy 1.
If this form is prepared as a Controlled Substance
Export Declaration, distribute as follows:
Copies 1, 2, and 3 shall accompany the shipment to
certain points.
Copy 1 shall remain with the shipment to its final
destination.
Copy 2 shall remain with the shipment, to be detached
and retained by the customs official of the foreign port of importation.
Copy 3 shall be removed by an official of the United
States Customs Service at the domestic port of exportation, certified and
signed by the customs official (after noting any discrepancies), and
forwarded to the Drug Enforcement Administration, Office of Diversion
Control, Import / Export
Unit (ODGI),
8701 Morrissette Drive, Springfield, VA 22152
Copy 4 shall be forwarded at least 15 days prior to
exportation to the Drug Enforcement Administration, Office of Diversion
Control, Import / Export Unit (OD GI),
8701 Morrissette Drive, Springfield, VA 22152. In cases where
the 15 day notice cannot be given, a special waiver may be requested from
the
Administration.
Copy 5 shall be retained by the exporter as part of
his records for a period of at least two years.
PRIVACY ACT INFORMATION
Authority: Sections 1002 and 1003 of the Controlled
Substances Act of 1970 (PL91-513), as amended (21
U.S.C. 952 and 953).
Purpose: To obtain information regarding the importation
of nonnarcotic substances in Schedules III, IV, and V and the exportation of nonnarcotic substances in Schedules III
and IV and all substances in Schedule V.
Routine Uses: The Controlled Substances Import/Export
Declaration produces special reports as required for statistical and law enforcement purposes. Disclosure of
information from this system are made to the following categories of users for the purposes
stated.
-
Other Federal law enforcement and regulatory agencies
for law enforcement purposes.
-
State and local law enforcement and regulatory agencies
for law enforcement and regulatory purposes.
Effect: Failure to complete this form will preclude
requested importation or exportation of the referenced controlled substances.
Under the Paperwork Reduction Act, a person is not
required to respond to a collection of information unless it displays a
currently valid OMB control number. Public reporting burden for this collection of
information is estimated to average 15 minutes per response, including the
time for reviewing instructions, searching existing data sources, gathering
and maintaining the data needed, and completing and reviewing the
collection of information. Send comments regarding this burden estimate or any other
aspect of this collection of information, including suggestions for
reducing this burden, to the Drug Enforcement Administration, FOI and Records
Management Section, Washington, D.C. 20537; and to the Office of
Management and Budget, Paperwork Reduction Project No. 1117-0009, Washington,
D.C. 20503.
|
